Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination. Glia. 2019.
Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell Stem Cell. 2019;25(4):473-485.e8.
Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation. Cell Stem Cell. 2019;25(4):531-541.e6.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination. Acta Neuropathol. 2015.
Astrocyte Activation via Stat3 Signaling Determines the Balance of Oligodendrocyte versus Schwann Cell Remyelination. Am J Pathol. 2015..
Discovery of a novel neuroprotectant, BHDPC, that protects against MPP(+)/MPTP-induced neuronal death in multiple experimental models. Free Radic Biol Med. 2015.
Regenerative Medicines for Remyelination: From Aspiration to Reality. Cell Stem Cell. 2015;16(6):576-577..
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. J Cell Biol. 2015;211(5):975-985.
Astrocyte response to motor neuron injury promotes structural synaptic plasticity via STAT3-regulated TSP-1 expression. Nat Commun. 2014;5:4294.
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med. 2014.
High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology. Stem Cell Reports. 2013;1(5):437-450..